Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma

Cancer Research

Volumn 66, Issue 19, 2006, Pages 9362-9368

  DeYoung, Maurice Phillip ^a,b   Johannessen, Cory M ^a,b,d   Leong, Chee Onn ^a,b   Faquin, William ^b,c   Rocco, James W ^a,b,c   Ellisen, Leif W ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; PROTEIN BCL 2; PROTEIN P63; PROTEIN P73;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EPITHELIUM CELL; GENE INDUCTION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; KERATINOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN INDUCTION; RNA INTERFERENCE; SENESCENCE; SQUAMOUS CELL CARCINOMA; TUMOR CELL; UPREGULATION;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA-BINDING PROTEINS; HUMANS; KERATINOCYTES; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PHOSPHOPROTEINS; RNA, SMALL INTERFERING; SKIN NEOPLASMS; TRANS-ACTIVATORS; TRANSDUCTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 33750378033     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-1619     Document Type: Article

References (20)

1. Mills AA, Zheng B, Wang XJ, et al. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999;398:708-13.
2. Yang A, Schweitzer R, Sun D, et al. p63 is essential for regenerative proliferation in limb, craniofacial, and epithelial development. Nature 1999;398:714-8.
3. Keyes WM, Wu Y, Vogel H, et al. p63 deficiency activates a program of cellular senescence and leads to accelerated aging. Genes Dev 2005;19:1986-99.
4. Hibi K, Trink B, Patturajan M, et al. AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci U S A 2000;97:5462-7.
5. Massion PP, Taflan PM, Jamshedur Rahman SM, et al. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res 2003;63:7113-21.
6. Sniezek JC, Matheny KE, Westfall MD, Pietenpol JA. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma. Laryngoscope 2004;114:2063-72.
7. Rocco JW, Leong CO, Kuperwasser N, et al. p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell 2006;9:45-56.
8. Ellisen LW, Ramsayer KD, Johannessen CM, et al. REDDI, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol Cell 2002;10:995-1005.
9. Dickson MA, Hahn WC, Ino Y, et al. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 2000;20:1436-47.
10. Ellisen LW, Carlesso N, Cheng T, et al. The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells. EMBO J 2001;20:1897-909.
11. Rubinson DA, Dillon CP, Kwiatkowski AV, et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells, and transgenic mice by RNA interference. Nat Genet 2003;33:401-6.
12. Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death inducing, and dominant negative activities. Mol Cell 1998;2:305-16.
13. Westfall MD, Mays DJ, Sniezek JC, Pietenpol JA. The ΔNp63α phosphoprotein binds the p21 and 14-3-3σ promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutants. Mol Cell Biol 2003;23:2264-76.
14. Lowe SW, Ruley HE, Jacks T, Houseman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;74:957-67.
15. Bowman T, Symonds H, Gu L, et al. Tissue-specific inactivation of p53 tumor suppression in the mouse. Genes Dev 1996;10:826-35.
16. Faridoni-Laurens L, Bosq J, Janot F, et al. P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63? Oncogene 2001;20:5302-12.
17. Choi HR, Batsakis JG, Zhan F, et al. Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis. Hum Pathol 2002;33:158-64.
18. Cui R, He J, Mei R, et al. Expression of p53, p63, and p73 isoforms in squamous cell carcinoma and adenocarcinoma of esophagus. Biochem Biophys Res Commun 2005;336:339-45.
19. Oberst A, Rossi M, Salomoni P, et al. Regulation of the p73 protein stability and degradation. Biochem Biophys Res Commun 2005;331:707-12.
20. Carroll DK, Carroll JS, Leong CO, et al. P63 regulates an adhesion program and cell survival in epithelial cells. Nat Cell Biol 2006;8:551-61.